ResMed Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	5,398	5,146	4,685	4,223	3,578	3,197
Revenue Growth (YoY)	9.57%	9.84%	10.95%	18.02%	11.93%	8.11%
Cost of Revenue	2,112	2,091	2,030	1,867	1,554	1,358
Gross Profit	3,286	3,055	2,655	2,356	2,024	1,839
Selling, General & Admin	1,048	991.02	917.14	874	737.51	670.39
Depreciation & Amortization Expenses	46.54	45.27	46.52	42.02	31.08	31.08
Research & Development	348.68	331.28	307.53	287.64	253.58	225.28
Other Operating Expenses	25.81	2.03	64.23	20.13	1.86	8.67
Total Operating Expenses	1,469	1,370	1,335	1,224	1,024	935.42
Operating Income	1,819	1,685	1,320	1,132	1,000	903.68
Interest Income	32.75	10.77	-39.82	-50.04	-1.62	-26.94
Other Non-Operating Income (Expense)	-14.15	-5.26	-3.49	14.52	3.2	0.3
Total Non-Operating Income (Expense)	-0.32	-7.8	-55.1	-30.21	-39.8	-20.02
Pretax Income	1,819	1,678	1,265	1,102	960.48	883.66
Provision for Income Taxes	332.81	276.84	243.85	204.11	181.05	409.16
Net Income	1,486	1,401	1,021	897.56	779.44	474.51
Net Income to Common	1,486	1,401	1,021	897.56	779.44	474.51
Net Income Growth	18.99%	37.20%	13.75%	15.15%	64.26%	-23.67%
Shares Outstanding (Basic)	146	147	147	147	146	145
Shares Outstanding (Diluted)	147	147	148	147	147	146
Shares Change (YoY)	-0.43%	-0.14%	0.06%	0.28%	0.40%	0.55%
EPS (Basic)	10.15	9.55	6.94	6.12	5.34	3.27
EPS (Diluted)	10.11	9.51	6.92	6.09	5.30	3.24
EPS Growth	19.36%	37.43%	13.63%	14.91%	63.58%	-24.12%
Free Cash Flow	1,792	1,662	1,302	573.63	216.31	634.01
Free Cash Flow Growth	7.82%	27.65%	126.94%	165.19%	-65.88%	-10.32%
Free Cash Flow Per Share	12.20	11.28	8.82	3.89	1.47	4.33
Dividends Per Share	2.260	2.120	1.920	1.760	1.680	1.590
Dividend Growth	6.60%	10.42%	9.09%	4.76%	5.66%	1.92%
Gross Margin	60.87%	59.36%	56.67%	55.78%	56.57%	57.53%
Operating Margin	33.70%	32.75%	28.17%	26.80%	27.96%	28.27%
Profit Margin	27.53%	27.22%	21.79%	21.25%	21.78%	14.84%
FCF Margin	33.19%	32.29%	27.78%	13.58%	6.05%	19.83%
EBITDA	2,065	1,921	1,536	1,329	1,194	1,095
EBITDA Margin	38.26%	37.33%	32.79%	31.48%	33.37%	34.26%
EBIT	1,819	1,685	1,320	1,132	1,000	903.68
EBIT Margin	33.70%	32.75%	28.17%	26.80%	27.96%	28.27%
Effective Tax Rate	18.30%	16.50%	19.28%	18.53%	18.85%	46.30%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q